PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28871303-6	2017	Polymeric dextrans coated with triazolylheptylmannoside (THM) ligands were highly potent, blocking the gB and DC-SIGN interaction at nanomolar concentrations.	Dextrans	10-18	CD209 molecule	Homo sapiens	110-117	
25224349-9	2014	We consider dextran a promising molecule for the development of lectin-glycan interaction-blocking molecules (such as DC-SIGN inhibitors) that could be applied in the treatment of diseases including tuberculosis, influenza, hepatitis B and C, human immunodeficiency virus infection and AIDS, etc.	Dextrans	12-19	CD209 molecule	Homo sapiens	118-125	
25224349-10	2014	Dextran derivatives indeed change the pathology of infections dependent on DC-SIGN and mannose receptors.	Dextrans	0-7	CD209 molecule	Homo sapiens	75-82